NIH Global Health Funding

In addition to Fogarty-supported programs and the trans-NIH programs and collaborations Fogarty is involved in, many Institutes and Centers at NIH offer funding opportunities to support research on global health topics, or in areas relevant to global health.

Current global health funding opportunities from across NIH

• BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa
  Exploratory / Developmental Phased Award (UG3/UH3 Clinical Trial Optional) (RFA-HL-20-009)
  Data Coordinating Center (DCC) (U24 Clinical Trial Not Allowed) (RFA-HL-20-010)
  UPDATED Expiration Date: June 12, 2019
• Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions (UG3/UH3 Clinical Trial Optional) (RFA-HL-20-005)
  Expiration Date: July 9, 2019
• U.S.-South Africa Program for Collaborative Biomedical Research Phase 2
  HIV/AIDS (R01 Clinical Trial Optional) (RFA-AI-19-022) and (U01 Clinical Trial Optional) (RFA-AI-19-023)
  Infectious Diseases (R01 Clinical Trial Optional) (RFA-AI-19-024) and (U01 Clinical Trial Optional) (RFA-AI-19-025)
  Expiration Date: July 27, 2019
• International Research in Infectious Diseases, including AIDS (R01) (PAR-17-142)
  Expiration Date: August 23, 2019
• Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) (Admin Supp) (PA-17-326)
  Expiration Date: Sep 19, 2019
• Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R01) (PA-17-194) and (R21) (PA-17-195)
  Expiration Date: January 8, 2020
• Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional) (PAR-18-023) and (R21 Clinical Trial Optional) (PAR-18-022)
  Expiration Date: January 8, 2020
• Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) (PAR-18-335)
  Expiration Date: August 1, 2020
• Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) (PAR-18-801) and (R41/R42 - Clinical Trial Optional) (PAR-18-802)
  Expiration Date: January 6, 2021
• International Research Collaboration on Drug Abuse and Addiction Research (R01 - Clinical Trial Optional) (PA-18-773)
  Expiration Date: May 8, 2021
• NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) (PAR-19-258)
  Expiration Date: September 8, 2021

Other NIH global health funding resources

• Search all NIH Funding Opportunities and Notices
• Subscribe to the NIH Weekly Guide for Grants and Contracts
• More about Global Health at NIH

Updated April 29, 2019